178 related articles for article (PubMed ID: 37961238)
1. Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patients.
Rajkumar S; Abdallah N; Lakshman A; Kumar S; Cook J; Binder M; Kapoor P; Dispenzieri A; Gertz M; Lacy M; Hayman S; Buadi F; Dingli D; Lin Y; Kourelis T; Warsame R; Bergsagel PL
Res Sq; 2023 Oct; ():. PubMed ID: 37961238
[TBL] [Abstract][Full Text] [Related]
2. Mode of progression in smoldering multiple myeloma: a study of 406 patients.
Abdallah NH; Lakshman A; Kumar SK; Cook J; Binder M; Kapoor P; Dispenzieri A; Gertz MA; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Lin Y; Kourelis T; Warsame R; Bergsagel L; Rajkumar SV
Blood Cancer J; 2024 Jan; 14(1):9. PubMed ID: 38228628
[TBL] [Abstract][Full Text] [Related]
3. Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey.
Mohyuddin GR; Chakraborty R; Cliff ERS; Derman BA
EClinicalMedicine; 2023 Nov; 65():102272. PubMed ID: 38046471
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Advances in the Management of Smoldering Myeloma.
Khan R; Zahid U; Kollu V; Jahan N; Ali M; Tricot G; Anwer F
Am J Ther; 2020; 27(2):e194-e203. PubMed ID: 31842112
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Management of Smoldering Multiple Myeloma.
Madhira BR; Konala VM; Adapa S; Naramala S; Ravella PM; Parikh K; Gentile TC
World J Oncol; 2020 Apr; 11(2):45-54. PubMed ID: 32284772
[TBL] [Abstract][Full Text] [Related]
6. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology.
Mateos MV; Landgren O
Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254
[TBL] [Abstract][Full Text] [Related]
7. [Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future].
Bhutani M; Landgren O
Radiologe; 2014 Jun; 54(6):572, 574-81. PubMed ID: 24927659
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C
Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821
[TBL] [Abstract][Full Text] [Related]
9. Timing treatment for smoldering myeloma: is earlier better?
Hernández JÁ; Martínez-López J; Lahuerta JJ
Expert Rev Hematol; 2019 May; 12(5):345-354. PubMed ID: 30907176
[TBL] [Abstract][Full Text] [Related]
10. Smoldering multiple myeloma: evolving diagnostic criteria and treatment strategies.
Visram A; Cook J; Warsame R
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):673-681. PubMed ID: 34889380
[TBL] [Abstract][Full Text] [Related]
11. Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage.
Wennmann M; Goldschmidt H; Mosebach J; Hielscher T; Bäuerle T; Komljenovic D; McCarthy PL; Merz M; Schlemmer HP; Raab MS; Sauer S; Delorme S; Hillengass J
Br J Haematol; 2022 Oct; 199(1):65-75. PubMed ID: 35608264
[TBL] [Abstract][Full Text] [Related]
12. Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics.
Sundararajan S; Kumar A; Korde N; Agarwal A
Curr Hematol Malig Rep; 2016 Apr; 11(2):102-10. PubMed ID: 26894382
[TBL] [Abstract][Full Text] [Related]
13. Smoldering Multiple Myeloma: Who and When to Treat.
Mateos MV; González-Calle V
Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):716-722. PubMed ID: 28709797
[TBL] [Abstract][Full Text] [Related]
14. Testing Mayo Clinic's New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study.
Tessier C; Allard T; Boudreault JS; Kaedbey R; Éthier V; Fortin F; Pavic M
Curr Oncol; 2021 May; 28(3):2029-2039. PubMed ID: 34073289
[TBL] [Abstract][Full Text] [Related]
15. Smoldering multiple myeloma requiring treatment: time for a new definition?
Dispenzieri A; Stewart AK; Chanan-Khan A; Rajkumar SV; Kyle RA; Fonseca R; Kapoor P; Bergsagel PL; McCurdy A; Gertz MA; Lacy MQ; Lust JA; Russell SJ; Zeldenrust SR; Reeder C; Roy V; Buadi F; Dingli D; Hayman SR; Leung N; Lin Y; Mikhael J; Kumar SK
Blood; 2013 Dec; 122(26):4172-81. PubMed ID: 24144641
[TBL] [Abstract][Full Text] [Related]
16. The Role of Early Intervention in High-Risk Smoldering Myeloma.
Joseph NS; Dhodapkar MV; Lonial S
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-9. PubMed ID: 32182141
[TBL] [Abstract][Full Text] [Related]
17. 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.
Musto P; Engelhardt M; Caers J; Bolli N; Kaiser M; Van de Donk N; Terpos E; Broijl A; De Larrea CF; Gay F; Goldschmidt H; Hajek R; Vangsted AJ; Zamagni E; Zweegman S; Cavo M; Dimopoulos M; Einsele H; Ludwig H; Barosi G; Boccadoro M; Mateos MV; Sonneveld P; Miguel JS
Haematologica; 2021 Nov; 106(11):2799-2812. PubMed ID: 34261295
[TBL] [Abstract][Full Text] [Related]
18. Smoldering Multiple Myeloma: To Treat or Not to Treat.
Kapoor P; Rajkumar SV
Cancer J; 2019; 25(1):65-71. PubMed ID: 30694862
[TBL] [Abstract][Full Text] [Related]
19. Understanding high-risk smoldering multiple myeloma.
Kreiniz N; Gertz MA
Leuk Lymphoma; 2023; 64(8):1361-1372. PubMed ID: 37229535
[TBL] [Abstract][Full Text] [Related]
20. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM).
Mateos MV; Kumar S; Dimopoulos MA; González-Calle V; Kastritis E; Hajek R; De Larrea CF; Morgan GJ; Merlini G; Goldschmidt H; Geraldes C; Gozzetti A; Kyriakou C; Garderet L; Hansson M; Zamagni E; Fantl D; Leleu X; Kim BS; Esteves G; Ludwig H; Usmani S; Min CK; Qi M; Ukropec J; Weiss BM; Rajkumar SV; Durie BGM; San-Miguel J
Blood Cancer J; 2020 Oct; 10(10):102. PubMed ID: 33067414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
